Cell Proliferation and Apoptosis in BRCA-Associated Hereditary Ovarian Cancer

Author： Levine D.A. Federici M.G. Reuter V.E. Boyd J.

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.85, Iss.3, 2002-06, pp. : 431-434

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

BRCA1 and BRCA2 mutations in Danish families with hereditary breast and/or ovarian cancer

By Thomassen Mads Hansen Thomas Borg Åke Theilmann Lianee Henriette Wikman Friedrik Søkilde Pedersen Inge Luise Bisgaard Marie Nielsen Finn Kruse Torben Gerdes Anne-Marie

Acta Oncologica, Vol. 47, Iss. 4, 2008-01 ,pp. : 772-777

Informa Healthcare

Access to resources Recommend Favorite

Novel BRCA1 and BRCA2 pathogenic mutations in Slovene hereditary breast and ovarian cancer families

International Journal of Oncology, Vol. 41, Iss. 5, 2012-01 ,pp. : 1619-1627

Spandidos Publications

Access to resources Recommend Favorite

Pneumocystis carinii Pneumonia in a Patient with Stage IV Ovarian Cancer

By Watanabe M. Aoki Y. Kurata H. Tanaka K.

Gynecologic Oncology, Vol. 87, Iss. 2, 2002-11 ,pp. : 225-227

Academic Press

Access to resources Recommend Favorite

Histology of Prophylactically Removed Ovaries from BRCA1 and BRCA2 Mutation Carriers Compared with Noncarriers in Hereditary Breast Ovarian Cancer Syndrome Kindreds

By Casey M.J. Bewtra C. Hoehne L.L. Tatpati A.D. Lynch H.T. Watson P.

Gynecologic Oncology, Vol. 78, Iss. 3, 2000-09 ,pp. : 278-287

Elsevier

Access to resources Recommend Favorite

Hypoxia-induced miR-210 in epithelial ovarian cancer enhances cancer cell viability via promoting proliferation and inhibiting apoptosis

International Journal of Oncology, Vol. 44, Iss. 6, 2014-01 ,pp. : 2111-2120

Spandidos Publications

Access to resources Recommend Favorite